Zeidan, A., Stein, A. S., Rimpiläinen, J., Pyörälä, M., Siitonen, T., Ball, B., Myllymäki, M., Zeidner, J., Searle, D. E., Witherall, R., Bono, P., Nimba, A., Williamson, J., Aakko, S., Hollmén, M., Kontro, M., Daver, N. (2025). Efficacy, molecular and translational analysis of TP53-mutated HR-MDS with bexmarilimab and azacitidine: Updated results from the bexmab Phase 1/2 study. Blood. https://doi.org/10.1182/blood-2025-236